Jersey Shore NJ
Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update
LEXINGTON, Mass., March 19, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of canc…
